(Q39544153)

12 September 2017

title

EDSS variability before randomization may limit treatment discovery in primary progressive MS. (English)

1 reference

12 September 2017

Emmanuelle Waubant

2

1 reference

12 September 2017

3

Gary Cutter

0 references

Jerry S Wolinsky

series ordinal

4

object named as

Jerry S Wolinsky

1 reference

12 September 2017

Jiameng Zhang

1

1 reference

12 September 2017

Robert Glanzman

series ordinal

5

1 reference

12 September 2017

publication date

1 October 2012

1 reference

Multiple Sclerosis Journal

12 September 2017

published in

1 reference

12 September 2017

volume

19

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

775-781

1 reference

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458512459685

Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512459685

The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512459685

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512459685

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512459685

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512459685

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512459685

Are quantitative functional measures more sensitive to worsening MS than traditional measures?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512459685

21 January 2018

Identifiers

DOI

10.1177/1352458512459685

1 reference

12 September 2017

1 reference